Tag:
Stents
Latest Headlines
Latest Headlines
Study: Zinc may be ideal for bioabsorbable stents
Zinc may be the ideal ingredient for bioabsorbable stents, new research from Michigan Technology University concludes.
German court sides with Boston Scientific rival in stent patent fight
Boston Scientific's ongoing stent patent fight against a smaller rival has taken a turn for the worse in a German court. OrbusNeich can now prevent the Massachusetts medical device giant from marketing certain stent models in Germany, thanks to a preliminary injunction that affirmed they violate two of its patents.
Altura Medical draws in $6M for AAA treatment device work
Altura Medical has grabbed $6 million in new venture equity financing, according to a regulatory filing.
Cook launches global trial of Zilver Vena stent
Cook Medical is working to get its Zilver Vena stent FDA approved, launching a global trial to study the device's benefits for patients with iliofemoral venous outflow obstruction.
Doctor accused of performing unnecessary stent procedures begins civil trial
A civil trial has begun for a Maryland cardiologist facing multiple lawsuits from patients alleging they were subjected to stent procedures that weren't ultimately needed.
Abbott lops off another 450 jobs at stent plant
Abbott Laboratories has laid off another 450 employees from its vascular division, this time targeting a San Diego-area plant that manufactures stents.
Boston Scientific unveils Promus Premier stent in Europe first
Even as stent manufacturers are bumping into each other in Europe vying for business, Boston Scientific ($BSX) is bringing yet another entry into the competition: The Promus Premier.
Indian stent makers target international markets
Indian stent makers are becoming increasingly viable competitors in international markets, adding another layer to an industry already crowded with a number of players.
Tryton raises $24M to get stent on U.S. market
Tryton Medical has pulled in $24 million in equity financing, looping all its investors to pitch in as it prepares to seek FDA approval for its Side Branch Stent to treat bifurcated lesions.
Biotronik targets FDA approval with stent trial
Biotronik has kicked off a multi-center investigational device trial for its Pulsar-18, targeting U.S. approval for its self-expanding device.
